Regeneron Pharmaceuticals has promised to comply with 23andMe's existing privacy polices while also using data to fuel drug discovery.
Add Yahoo as a preferred source to see more of our stories on Google. 23andMe headquarters in Sunnyvale, Calif. (Tayfun Coskun/Anadolu via Getty Images) Today is the deadline for customers of the ...
The sale of 23andMe was finalized this week, following the company filing for bankruptcy in March. The sale was previously approved by a judge. The company was purchased by the nonprofit TTAM Research ...
23andMe has filed for bankruptcy as is seeking buyers. Here's what could happen to the company's DNA database, one of the ...
Changes in two genes appear to help predict whether patients will lose substantial weight on GLP-1 drugs — and whether the ...
The bidding competition over 23andMe may not be over. The founder of 23andMe, Anne Wojcicki, has asked a federal bankruptcy court judge to reopen an auction for the genetic testing company, saying she ...
Regeneron Pharmaceuticals announced on Monday that it will acquire "substantially all" of genetic testing company 23andMe's assets. The pharmaceutical company said it won the court-supervised auction ...
Bankrupt 23andMe is facing a lawsuit over its plans to sell customer genetic information. Twenty-seven states and the District of Columbia took legal action this week against 23andMe in the U.S.
FIRST ON FOX: Republican senators John Cornyn and Chuck Grassley and Democratic Sen. Amy Klobuchar are rolling out a bipartisan measure to protect sensitive genetic data in response to privacy ...
NEW YORK (AP) — Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight. AI is a gold mine for spammers and scammers, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results